Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear

Allergan

Status and phase: Completed; Phase 3; Phase 2

Conditions: Ametropia

Treatments: Device: Carboxymethylcellulose sodium; Device: Carboxymethylcellulose sodium and Glycerin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00691197

AG9689-002

Details and patient eligibility

About

Testing the Safety and Acceptability of Using a Rewetting Drop with Contact Lenses

Enrollment: 246 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adapted contact lens wearer

Exclusion criteria

• Monovision lens wearer, ocular or systemic disease, pregnant or planning to become pregnant

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

246 participants in 2 patient groups

Carboxymethylcellulose sodium and Glycerin

Experimental group

Description:

Carboxymethylcellulose sodium and Glycerin based rewetting drop

Treatment:

Device: Carboxymethylcellulose sodium and Glycerin

Carboxymethylcellulose sodium

Active Comparator group

Description:

Carboxymethylcellulose sodium based rewetting drop

Treatment:

Device: Carboxymethylcellulose sodium